Cytogenetic risk-associated outcomes of antithymocyte globulin use in HLA-matched sibling transplantation for acute myeloid leukemia.

Ann Hematol · 2025 · PMC12672648 · PMID 41099849

Europe PMC DOI

hedged sentences

0.0710

closest p · 1.4× alpha

0.0710

boldest claim

The sentences

showed a trendp = 0.071so close (0.05 < p ≤ 0.1)

No significant differences in OS, cGRFS, cGvHD, relapse, or NRM were observed between the two dose groups, although EFS showed a trend favoring 2.5 mg/kg ( p = 0.071; Supplementary Fig. 5 ).

also in 53,322 other papers

did not reach statistical significanceno p-value reported

After IPTW weighting, the results were similar, with ATG showing only a trend toward inferior EFS ( p = 0.09) and increased relapse risk ( p = 0.08), which did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.